GLYcoDiag is proud to announce its participation as beneficiary to HORIZON-TMA-MSCA-DN program called AUREUS

glycodiag-news-featured-default

The AUREUS doctoral network (DN) meets the increasing need of a highly qualified work force to counteract multidrug-resistant S.aureus infections by performing cutting-edge, inter-disciplinary research in the multifaceted field of chemical biology. The AUREUS network will provide 14 young scientists with broad, top-class scientific and professional competences and skills, thereby expanding the pipeline of future leaders for both industry and academia.